Dimensional Fund Advisors LP Roivant Sciences Ltd. Transaction History
Dimensional Fund Advisors LP
- $405 Billion
- Q4 2024
A detailed history of Dimensional Fund Advisors LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 131,314 shares of ROIV stock, worth $1.36 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
131,314
Previous 202,941
35.29%
Holding current value
$1.36 Million
Previous $2.34 Million
33.66%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
331Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$683 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$644 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$496 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$458 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$367 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.31B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...